Human cytomegalovirus

Nov 30, 2018

FDA authorizes first test to aid in detecting a type of herpes virus in newborns called cytomegalovirus

Jun 19, 2018

Artemis Therapeutics Announces Two Recent Publications Highlighting Artemisone's Activity Against Human Cytomegalovirus And Malaria

Jun 12, 2018

Data Presented At The 31st International Conference For Antiviral Research Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication

Jun 07, 2018

New Data Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication

Apr 16, 2018

Artemis Therapeutics Announces Additional Patent Issuance For Artemisone For The Treatment Of Viral Infections

Jan 22, 2018

Astellas and Vical Announce Top-Line Results for Phase 3 Trial of Cytomegalovirus Vaccine ASP0113 in Hematopoietic Stem Cell Transplant Recipients

Dec 06, 2017

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2017

Nov 28, 2017

Artemis Therapeutics Announces Issuance Of European Patent For Artemisone For The Treatment Of Viral Infections

Oct 26, 2017

Artemis Therapeutics Appoints Brian M. Culley As Chief Executive Officer

Jun 06, 2017

QIAGEN receives U.S. FDA approval for cytomegalovirus (CMV) testing on automated QIAsymphony platform

Jun 05, 2017

Roche receives FDA approval for CMV viral load testing on cobas® 6800/8800 Systems